Clinical Trial Update: A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain [Phase 2]

View source ↗

Summary

Phase 2 randomized, open-label, single-dose study evaluating the safety and effectiveness of hydromorphone for short-term postoperative pain; status indicates t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Postoperative, Orthopedic Procedures | Phase 2 | Status: COMPLETED